Last Posted: Jul 25, 2019
- Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications.
Zhang Frederick et al. Pharmacogenomics and personalized medicine 2019 12107-123 - Patient and Health Care Provider Needs and Preferences in Understanding Pharmacogenomic and Genomic Testing: A Meta-Data Analysis.
Veilleux Sophie et al. Qualitative health research 2019 Jul 1049732319858325 - Ready or not, here it comes: Direct-to-consumer pharmacogenomic testing and its implications for community pharmacists.
Gammal Roseann S et al. Journal of the American Pharmacists Association : JAPhA 2019 Jul - Genetic testing for prevention of severe drug-induced skin rash.
Alfirevic Ana et al. The Cochrane database of systematic reviews 2019 Jul 7CD010891 - Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects.
Gill Dipender et al. Circulation 2019 Jul (4) 270-279 - Diversity in the Era of Precision Medicine - From Bench to Bedside Implementation
A Mamun et al, Ethnicity and Disease, July 2019 - Pharmacogenomics Clinical Annotation Tool (PharmCAT).
Sangkuhl Katrin et al. Clinical pharmacology and therapeutics 2019 Jul - Pharmacogenomics, CYP2D6, and Tamoxifen: A Survey of the Reasons Sustaining European Clinical Practice Paradigms.
Reis Sara S et al. Medicina (Kaunas, Lithuania) 2019 Jul 55(7) - Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies.
Richardson Marty et al. BMJ open 2019 Jul 9(7) e030212 - A Review of African Americans' Beliefs and Attitudes About Genomic Studies: Opportunities for Message Design.
Scherr Courtney L et al. Frontiers in genetics 2019 10548
.png)
No hay comentarios:
Publicar un comentario